INSPIRATION HEALTHCARE GROUP PLC

Declaration of Voting Results & Voting Rights Announcements • Jun 10, 2022

National Storage Mechanism | Additional information

RNS Number : 5078O

Inspiration Healthcare Group PLC

10 June 2022

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Exercise of options and Total Voting Rights

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company announces that, pursuant to the exercise of options at nil cost under the Inspiration Healthcare Group plc Long Term Incentive Plan (the "LTIP") by an employee of the Group, a total of 6,250 new ordinary shares of 10p each in the Company ("New Ordinary Shares") have been issued and allotted by the Company.

The Company further announces that it has received notice of the exercise of options in relation to employee share options over 2,909 New Ordinary Shares issued under the Company's Sharesave Scheme.

Application has been made for an aggregate of 9,159 New Ordinary Shares to be admitted to AIM ("Admission") and such Admission is expected to become effective at 8.00am on or around 15 June 2022. The New Ordinary Shares shall rank pari passu with the existing Ordinary Shares in issue.

Total Voting Rights

For the purpose of the Disclosure Guidance and Transparency Rules of the FCA, following the above issue of New Ordinary Shares, the issued share capital of the Company will comprise 68,130,606 Ordinary Shares. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer	Tel: 01455 840555
Nominated Adviser & Broker Cenkos Securities plc Stephen Keys Mark Connelly Katy Birkin Dan Hodkinson	Tel: 0207 397 8900
Cadogan PR                                                                                          Alex Walters alex.walters@cadoganpr.com	Tel: 07771 713608

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries.  Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products.  The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at  www.inspirationhealthcaregroup.plc.uk  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCURVARUSUNAAR